Meloxan

Meloxicam, the active ingredient in Meloxan, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adults.

GNH USA supplies Meloxan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under strict quality controls. It is distributed through GNH USA's global logistics network, ensuring timely delivery to authorized healthcare providers.

Meloxan (meloxicam) is employed in the management of inflammatory joint and musculoskeletal disorders. - Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: alleviates inflammation and slows progression of joint damage. - Ankylosing spondylitis: decreases spinal pain and stiffness, enhancing posture. - Acute musculoskeletal pain: provides rapid relief of pain and inflammation.

Meloxan may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Abdominal pain - Diarrhea - Headache

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding - Cardiovascular thrombotic events - Severe skin reactions such as Stevens‑Johnson syndrome

Before prescribing Meloxan, clinicians should consider several precautionary measures to minimize risk. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor cardiovascular status: use cautiously in patients with heart disease or risk factors. - Check renal function: adjust or avoid in severe renal impairment. - Review hepatic function: avoid in patients with significant liver disease. - Avoid concomitant anticoagulants: increased risk of bleeding when combined with warfarin or similar agents. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Meloxan can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or high‑dose aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased chance of bleeding.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal clearance of meloxicam. - Lithium: potential for increased lithium levels and toxicity.